<unk>  is an antidiabetic drug in the class of medications known as meglitinides, and was invented in 1983.<unk>  is an oral medication used in addition to diet and exercise for blood sugar control in type 2 diabetes mellitus. The mechanism of action of<unk>  involves promoting insulin release from β-islet cells of the pancreas; like other antidiabetic drugs, a main side effect concern is hypoglycemia. It is sold by Novo Nordisk under the name of Prandin in the United States, GlucoNorm in Canada, Surepost in Japan,<unk>  in Egypt by EIPICO, and NovoNorm elsewhere. In Japan it is produced by Dainippon Sumitomo Pharma.
Repaglinide
Liraglutide
Linagliptin
Exenatide
Vildagliptin
Insulin glulisine
Insulin degludec
Miglitol